Outbreak of contact allergy to dicyclohexylcarbodiimide in a biotechnology laboratory
Contact Dermatitis · 2025
DOI: 10.1111/cod.14715 ↗At a glance
Journal article in Contact Dermatitis, 2025. Written by Linas Griguola and 5 co-authors. Institution: Pulmonology and Allergology Center, VUH Santaros Klinikos, Vilnius, Lithuania. Major MEDLINE topics: Dermatitis, Allergic Contact, Patch Tests, Dermatitis, Occupational, Dicyclohexylcarbodiimide. Cited 4 times so far (Crossref); 25 references.
Abstract (original language)
Background
Dicyclohexylcarbodiimide (DCC) is known to cause occupational allergic contact dermatitis in biotechnology laboratory workers.
Objectives
This study aimed to assess the prevalence of DCC sensitization among workers of one biosynthesis laboratory and to determine the optimal DCC concentration for patch testing. Materials and methods 23 laboratory workers frequently exposed to DCC of whom 21 suffered from dermatitis and 11 controls were enrolled into the study. All participants underwent skin patch testing with different concentrations of DCC and other substances used in the work environment. Statistical analysis was conducted to compare results between active and control groups.
Results
Of the 23 workers tested, 56.5% showed positive reactions to DCC. All of them had dermatitis. Morpholine also elicited positive reactions in 26.1% of workers who were all sensitized to DCC. Dimethylformamide and chloroform yielded negative results.
Conclusion
Dicyclohexylcarbodiimide was a major cause of contact dermatitis in the active group indicating an outbreak of contact allergy to DCC in the company necessitating preventive measures. Both DCC 0.1% ac. and DCC 0.05% pet. should both be used for patch testing.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Pulmonology and Allergology Center, VUH Santaros Klinikos, Vilnius, Lithuania.
- Clinic of Chest Diseases, Immunology and Allergology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
ORCID profiles: Linas Griguola, Laura Malinauskiene
Cite
APA
Griguola, L., Cerniauskas, K., Malinauskiene, L., Linauskiene, K., Rudyte, J., & Chomiciene, A. (2025). Outbreak of contact allergy to dicyclohexylcarbodiimide in a biotechnology laboratory. Contact Dermatitis. https://doi.org/10.1111/cod.14715
Vancouver
Griguola L, Cerniauskas K, Malinauskiene L, Linauskiene K, Rudyte J, Chomiciene A. Outbreak of contact allergy to dicyclohexylcarbodiimide in a biotechnology laboratory. Contact Dermatitis. 2025. doi:10.1111/cod.14715
BibTeX
@article{Griguola2025,
author = {Griguola, Linas and Cerniauskas, Kestutis and Malinauskiene, Laura and Linauskiene, Kotryna and Rudyte, Justina and Chomiciene, Anzelika},
title = {Outbreak of contact allergy to dicyclohexylcarbodiimide in a biotechnology laboratory},
journal = {Contact Dermatitis},
year = {2025},
doi = {10.1111/cod.14715}
}
EUVIMED